Literature DB >> 25355536

Overexpression of ZFX and its involvement in squamous cell carcinoma of the tongue.

Jirong Yin1, Yi Jiang1, Hao Wu1, Juncheng Wang1, Shanchuang Zhang1, Hongchen Liu1.   

Abstract

Zinc finger protein, X-linked (ZFX) has been identified as a transcriptional factor and is implicated in the development of variant types of cancer. Furthermore, it has been reported that ZFX is essential for the survival and self-renewal of embryonic stem cells. To investigate the involvement of ZFX in squamous cell carcinoma of the tongue, in the present study, we explored the expression of ZFX in clinical specimens from patients with squamous cell carcinoma of the tongue and the correlation between ZFX expression and multiple clinical pathological parameters. We further evaluated the impact of ZFX knockdown on the proliferation, colony formation ability, cell cycle distribution and survival of two human tongue squamous cell carcinoma cell lines to explore its critical role in the development of squamous cell carcinoma of the tongue. Our results showed that ZFX expression was aberrantly higher in samples from patients with squamous cell carcinoma of the tongue and revealed that ZFX expression is positively correlated with tumor grade and stage. Consistent with these findings, we further found that ZFX knockdown impaired cell proliferation and colony formation ability and induced cell apoptosis and cell cycle arrest in two human tongue squamous cell carcinoma cell lines. Our results indicate that ZFX is essential for the development and progression of squamous cell carcinoma of the tongue and represents a potential target for the development of effective therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25355536     DOI: 10.3892/or.2014.3572

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  2 in total

1.  High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients.

Authors:  Xuebing Yan; Zezhi Shan; Leilei Yan; Qingchao Zhu; Liguo Liu; Bing Xu; Sihong Liu; Zhiming Jin; Yuping Gao
Journal:  Oncotarget       Date:  2016-04-12

2.  ZFX is a Strong Predictor of Poor Prognosis in Renal Cell Carcinoma.

Authors:  Changying Li; Hongjie Li; Ting Zhang; Jianmin Li; Fuling Ma; Mei Li; Zhifang Sui; Jiwu Chang
Journal:  Med Sci Monit       Date:  2015-11-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.